Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Challenges in the Diagnosis and Management of Bacterial Lung Infections in Solid Organ Recipients: A Narrative Review.

Carugati M, Morlacchi LC, Peri AM, Alagna L, Rossetti V, Bandera A, Gori A, Blasi F, Working Group I.

Int J Mol Sci. 2020 Feb 12;21(4). pii: E1221. doi: 10.3390/ijms21041221. Review.

PMID:
32059371
2.

Re: Best Practice Statement on Urologic Procedures and Antimicrobial Prophylaxis.

Mangioni D, Rocchini L, Bandera A, Montanari E.

J Urol. 2020 Jan 31:101097JU0000000000000789. doi: 10.1097/JU.0000000000000789. [Epub ahead of print] No abstract available.

PMID:
32003615
3.

Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome.

Grasselli G, Scaravilli V, Alagna L, Bombino M, De Falco S, Bandera A, Abbruzzese C, Patroniti N, Gori A, Pesenti A.

Ann Intensive Care. 2019 Dec 18;9(1):141. doi: 10.1186/s13613-019-0615-7.

4.

Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.

Peri AM, Rossio R, Tafuri F, Benzecry V, Grancini A, Reda G, Bandera A, Peyvandi F.

Ann Hematol. 2019 Dec;98(12):2847-2849. doi: 10.1007/s00277-019-03837-1. Epub 2019 Nov 18. No abstract available.

PMID:
31741032
5.

Towards Rapid Sepsis Diagnosis and Patients Stratification: What's New From Microbiology and Omics Science.

Mangioni D, Peri AM, Rossolini GM, Viaggi B, Perno CF, Gori A, Bandera A.

J Infect Dis. 2019 Nov 6. pii: jiz585. doi: 10.1093/infdis/jiz585. [Epub ahead of print]

PMID:
31693109
6.

[Vascular access survey in the Triveneto area: data analysis for the year 2017].

Veniero P, Zarantonello D, Axia M, Bandera A, Bosco M, Boscutti G, Crepaldi C, Dugo M, Martimbianco L, Martone M, Scaparrotta G, Tabbì MG, Valente F, Fiorini F.

G Ital Nefrol. 2019 Sep 24;36(5). pii: 2019-vol5. Italian.

PMID:
31580549
7.

Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances.

Lapadula G, Bernasconi DP, Bai F, Focà E, Di Biagio A, Bonora S, Castelli F, Squillace N, Bandera A, Monforte AD, Migliorino GM, Gori A; SWEAR Study Group.

AIDS. 2020 Jan 1;34(1):53-61. doi: 10.1097/QAD.0000000000002377.

PMID:
31567160
8.

Combination Antifungal Therapy for Invasive Mold Infections Among Pediatric Patients with Hematological Malignancies: Data from A Real-Life Case-Series.

Peri AM, Verna M, Biffi S, Alagna L, Longhi B, Migliorino GM, Foresti S, Bandera A, Rovelli A, Rizzari C, Gori A, Colombini A.

Pathog Immun. 2019 Sep 5;4(2):180-194. doi: 10.20411/pai.v4i2.299. eCollection 2019.

9.

HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?

Bandera A, Taramasso L, Bozzi G, Muscatello A, Robinson JA, Burdo TH, Gori A.

Front Aging Neurosci. 2019 Aug 2;11:187. doi: 10.3389/fnagi.2019.00187. eCollection 2019.

10.

Immunonutrition in Human Immunodeficiency Virus Infection: Which Populations to Target?

Taramasso L, Bozzi G, Muscatello A, Bandera A, Gori A.

Clin Infect Dis. 2019 Nov 27;69(12):2228-2229. doi: 10.1093/cid/ciz337. No abstract available.

PMID:
31321413
11.

Recurrent posterior reversible encephalopathy syndrome in an HIV-HCV coinfected liver transplant recipient.

Cappelletti A, Peri AM, Bisi L, Sabbatini F, Rossi M, Migliorino GM, Foresti S, Bandera A, Gori A.

AIDS. 2019 Aug 1;33(10):1679-1681. doi: 10.1097/QAD.0000000000002258. No abstract available.

PMID:
31305337
12.

Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients.

Fabbiani M, Ciccarelli N, Castelli V, Soria A, Borghetti A, Colella E, Moschese D, Valsecchi M, Emiliozzi A, Gori A, De Luca A, Bandera A, Di Giambenedetto S.

J Neurovirol. 2019 Dec;25(6):866-873. doi: 10.1007/s13365-019-00780-9. Epub 2019 Jul 7.

PMID:
31281946
13.

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection.

Giacomelli A, Fabbiani M, De Benedetto I, Nozza S, Focà E, Celesia BM, Marchetti G, Mussini C, Antinori A, d'Ettorre G, Madeddu G, Bandera A, Muscatello A, Rusconi S.

J Med Virol. 2019 Oct;91(10):1891-1895. doi: 10.1002/jmv.25517. Epub 2019 Jun 27.

PMID:
31199538
14.

Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins.

Mangioni D, Grasselli G, Abbruzzese C, Muscatello A, Gori A, Bandera A.

Int J Infect Dis. 2019 Aug;85:70-73. doi: 10.1016/j.ijid.2019.05.022. Epub 2019 May 24.

15.

Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV.

Squillace N, Soria A, Bozzi G, Gori A, Bandera A.

Expert Rev Gastroenterol Hepatol. 2019 Jul;13(7):643-650. doi: 10.1080/17474124.2019.1614913. Epub 2019 May 13. Review.

PMID:
31081390
16.

Phylogenies in ART: HIV reservoirs, HIV latency and drug resistance.

Bandera A, Gori A, Clerici M, Sironi M.

Curr Opin Pharmacol. 2019 Oct;48:24-32. doi: 10.1016/j.coph.2019.03.003. Epub 2019 Apr 28. Review.

PMID:
31029861
17.

Transcriptome profiling and fast microbiology in sepsis diagnosis: A potential synergy we cannot neglect.

Mangioni D, Bandera A, Peri AM, Muscatello A, Gori A.

J Crit Care. 2019 Aug;52:267-268. doi: 10.1016/j.jcrc.2019.03.005. Epub 2019 Mar 20. No abstract available.

PMID:
30917890
18.

Microbiota in ICU, not only a gut problem.

Alagna L, Bandera A, Patruno A, Muscatello A, Citerio G, Gori A.

Intensive Care Med. 2019 May;45(5):733-737. doi: 10.1007/s00134-018-05516-7. Epub 2019 Jan 22. No abstract available.

PMID:
30671622
19.

Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era.

Squillace N, Bozzi G, Colella E, Gori A, Bandera A.

Drug Des Devel Ther. 2018 Oct 29;12:3635-3643. doi: 10.2147/DDDT.S147493. eCollection 2018. Review.

20.

Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.

Salgado M, Kwon M, Gálvez C, Badiola J, Nijhuis M, Bandera A, Balsalobre P, Miralles P, Buño I, Martinez-Laperche C, Vilaplana C, Jurado M, Clotet B, Wensing A, Martinez-Picado J, Diez-Martin JL; IciStem Consortium.

Ann Intern Med. 2018 Nov 20;169(10):674-683. doi: 10.7326/M18-0759. Epub 2018 Oct 16. Erratum in: Ann Intern Med. 2019 Jan 1;170(1):80.

PMID:
30326031
21.

The contribution of immune activation and accelerated aging in multiple myeloma occurring in HIV-infected population.

Bandera A, Colella E, Clerici M, Rizzardini G, Gori A.

AIDS. 2018 Nov 28;32(18):2841-2846. doi: 10.1097/QAD.0000000000002015. Review.

PMID:
30234600
22.

Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment.

Giacobbe DR, di Masi A, Leboffe L, Del Bono V, Rossi M, Cappiello D, Coppo E, Marchese A, Casulli A, Signori A, Novelli A, Perrone K, Principe L, Bandera A, Vender LE, Misin A, Occhilupo P, Melone M, Ascenzi P, Gori A, Luzzati R, Viscoli C, Di Bella S.

Sci Rep. 2018 Aug 10;8(1):11968. doi: 10.1038/s41598-018-30361-5.

23.

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy.

Saracino A, Zaccarelli M, Lorenzini P, Bandera A, Marchetti G, Castelli F, Gori A, Girardi E, Mussini C, Bonfanti P, Ammassari A, d'Arminio Monforte A; Icona Foundation Study Group.

BMC Public Health. 2018 Jul 13;18(1):870. doi: 10.1186/s12889-018-5804-z.

24.

Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen.

Squillace N, Trabattoni D, Muscatello A, Sabbatini F, Maloberti A, Giannattasio C, Masetti M, Fenizia C, Soria A, Clerici M, Gori A, Bandera A.

J Antimicrob Chemother. 2018 Aug 1;73(8):2162-2170. doi: 10.1093/jac/dky178.

PMID:
29897513
25.

Special issue on cognitive robotics.

Bandera A, Dias J, Vincze M, Manso LJ.

Cogn Process. 2018 May;19(2):231-232. doi: 10.1007/s10339-018-0863-8. Epub 2018 Apr 16. No abstract available.

PMID:
29658054
26.

Vaginosis-associated bacteria and its association with HPV infection.

Romero-Morelos P, Bandala C, Jiménez-Tenorio J, Valdespino-Zavala M, Rodríguez-Esquivel M, Gama-Ríos RA, Bandera A, Mendoza-Rodríguez M, Taniguchi K, Marrero-Rodríguez D, López-Romero R, Ramón-Gallegos E, Salcedo M.

Med Clin (Barc). 2019 Jan 4;152(1):1-5. doi: 10.1016/j.medcli.2018.01.027. Epub 2018 Mar 12. English, Spanish.

PMID:
29544661
27.

The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery.

Bandera A, Masetti M, Fabbiani M, Biasin M, Muscatello A, Squillace N, Clerici M, Gori A, Trabattoni D.

Front Immunol. 2018 Feb 12;9:214. doi: 10.3389/fimmu.2018.00214. eCollection 2018.

28.

Invasive aspergillosis with pulmonary and central nervous system involvement during ibrutinib therapy for relapsed chronic lymphocytic leukaemia: case report.

Peri AM, Bisi L, Cappelletti A, Colella E, Verga L, Borella C, Foresti S, Migliorino GM, Gori A, Bandera A.

Clin Microbiol Infect. 2018 Jul;24(7):785-786. doi: 10.1016/j.cmi.2018.01.028. Epub 2018 Feb 7. No abstract available.

29.

Higher Levels of Peripheral Th17 T CD4+ Cells Are Associated With Immunological Non Response in HIV-Infected Patients Under Effective ART.

De Benedetto I, Masetti M, Fabbiani M, Biasin M, Muscatello A, Squillace N, Clerici M, Trabattoni D, Gori A, Bandera A.

J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):e45-e47. doi: 10.1097/QAI.0000000000001627. No abstract available.

PMID:
29315114
30.

Acute Human Immunodeficiency Virus (HIV) Infection Presenting With Bilateral Interstitial Pneumonia: Case Report and Discussion of Potential HIV-Induced Interstitial Pneumonia.

Peri AM, Alagna L, Trovati S, Sabbatini F, Rona R, Simonetti FR, Foresti S, Migliorino GM, Gori A, Bandera A.

Open Forum Infect Dis. 2017 Nov 20;4(4):ofx256. doi: 10.1093/ofid/ofx256. eCollection 2017 Fall.

31.

Structural and Biophysical Analysis of the Soluble DHH/DHHA1-Type Phosphodiesterase TM1595 from Thermotoga maritima.

Drexler DJ, Müller M, Rojas-Cordova CA, Bandera AM, Witte G.

Structure. 2017 Dec 5;25(12):1887-1897.e4. doi: 10.1016/j.str.2017.10.001. Epub 2017 Oct 26.

32.

Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.

Cingolani A, Cozzi Lepri A, Teofili L, Galli L, Mazzotta V, Baldin GM, Hohaus S, Bandera A, Alba L, Galizzi N, Castagna A, D'arminio Monforte A, Antinori A; ICONA Foundation Study group.

PLoS One. 2017 Oct 31;12(10):e0186549. doi: 10.1371/journal.pone.0186549. eCollection 2017.

33.

Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.

Bandera A, De Benedetto I, Bozzi G, Gori A.

Curr Opin HIV AIDS. 2018 Jan;13(1):73-80. doi: 10.1097/COH.0000000000000429. Review.

PMID:
29045252
34.

Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.

Re A, Gini G, Rupolo M, Levis A, Bandera A, Liberati AM, Tozzi P, Cattaneo C, Casari S, Skert C, Bocci C, Spina M, Allione B, Verga L, Michieli M, Almici C, Leali PF, Tirelli U, Rossi G.

Bone Marrow Transplant. 2018 Feb;53(2):228-230. doi: 10.1038/bmt.2017.230. Epub 2017 Oct 9. No abstract available.

PMID:
28991244
35.

Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated With the Evolution of Cognitive Performance in HIV-Infected Patients.

Fabbiani M, Muscatello A, Perseghin P, Bani M, Incontri A, Squillace N, Lapadula G, Gori A, Bandera A.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):219-224. doi: 10.1097/QAI.0000000000001480.

PMID:
28902679
36.

Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression.

Gianotti N, Marchetti G, Antinori A, Saracino A, Gori A, Rizzardini G, Lichtner M, Bandera A, Mussini C, Girardi E, dʼArminio Monforte A, Cozzi-Lepri A.

J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):417-422. doi: 10.1097/QAI.0000000000001522.

PMID:
28816721
37.

3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir.

Gagliardini R, Bandera A, Zaccarelli M, Sterrantino G, Latini A, D'Avino A, Lapadula G, Antinori A, Cauda R, De Luca A, Gori A, Di Giambenedetto S, Fabbiani M.

Antivir Ther. 2018;23(2):139-148. doi: 10.3851/IMP3188.

PMID:
28799920
38.

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project.

Squillace N, Ricci E, Quirino T, Gori A, Bandera A, Carenzi L, De Socio GV, Orofino G, Martinelli C, Madeddu G, Rusconi S, Maggi P, Celesia BM, Cordier L, Vichi F, Calza L, Falasca K, Di Biagio A, Pellicanò GF, Bonfanti P; CISAI Study Group.

PLoS One. 2017 Jun 20;12(6):e0179254. doi: 10.1371/journal.pone.0179254. eCollection 2017.

39.

Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study.

Raffetti E, Donato F, Casari S, Castelnuovo F, Sighinolfi L, Bandera A, Maggiolo F, Ladisa N, di Pietro M, Fornabaio C, Digiambenedetto S, Quiros-Roldan E.

BMC Infect Dis. 2017 Mar 7;17(1):193. doi: 10.1186/s12879-017-2280-5.

40.

Clinical Usefulness of Klebsiella Pneumoniae Carbapenemase-Producing K. Pneumoniae Genotyping: The Experience of a Single-Center Epidemic.

Rossi M, Chatenoud L, Viganò EF, Peri AM, Alagna L, Bramati S, Manenti M, Raggi M, Cavallero A, Bisi L, Leone S, Migliorino GM, Bandera A, Gori A.

Pathog Immun. 2017 Jan 9;1(2):352-370. doi: 10.20411/pai.v1i2.109. eCollection 2016.

41.

Occupational HIV Infection in a Research Laboratory With Unknown Mode of Transmission: A Case Report.

Soria A, Alteri C, Scarlatti G, Bertoli A, Tolazzi M, Balestra E, Bellocchi MC, Continenza F, Carioti L, Biasin M, Trabattoni D, Bandera A, Ceccherini-Silberstein F, Perno CF, Gori A.

Clin Infect Dis. 2017 Mar 15;64(6):810-813. doi: 10.1093/cid/ciw851.

42.

Data-Driven Multiresolution Camera Using the Foveal Adaptive Pyramid.

González M, Sánchez-Pedraza A, Marfil R, Rodríguez JA, Bandera A.

Sensors (Basel). 2016 Nov 26;16(12). pii: E2003.

43.

Strategies to limit immune-activation in HIV patients.

Bandera A, Colella E, Rizzardini G, Gori A, Clerici M.

Expert Rev Anti Infect Ther. 2017 Jan;15(1):43-54. Epub 2016 Nov 4. Review.

PMID:
27762148
44.

High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort.

Squillace N, Galli L, Bandera A, Castagna A, Madeddu G, Caramello P, Antinori A, Cattelan A, Maggiolo F, Cingolani A, Gori A, Monforte Ad; ICONA Foundation Study Group.

Medicine (Baltimore). 2016 Sep;95(36):e4434. doi: 10.1097/MD.0000000000004434.

45.

Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART.

Squillace N, Lorenzini P, Lapadula G, Bandera A, Cozzi-Lepri A, Rusconi S, Puoti M, Castagna A, Antinori A, Gori A, d'Arminio Monforte A; Icona Foundation Study Group.

J Antimicrob Chemother. 2016 Sep;71(9):2663-9. doi: 10.1093/jac/dkw185. Epub 2016 Jun 5.

PMID:
27272727
46.

In vivo real time non invasive monitoring of brain penetration of chemicals with near-infrared spectroscopy: Concomitant PK/PD analysis.

Crespi F, Cattini S, Donini M, Bandera A, Rovati L.

J Neurosci Methods. 2016 Jan 30;258:79-86. doi: 10.1016/j.jneumeth.2015.10.011. Epub 2015 Nov 6.

PMID:
26549641
47.

Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter Study.

Raffetti E, Donato F, Pezzoli C, Digiambenedetto S, Bandera A, Di Pietro M, Di Filippo E, Maggiolo F, Sighinolfi L, Fornabaio C, Castelnuovo F, Ladisa N, Castelli F, Quiros Roldan E.

J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):585-92. doi: 10.1097/QAI.0000000000000682.

PMID:
26167619
48.

Similar Success Rates but Lower Incidence of Telaprevir-Related Rash in HIV/HCV Coinfected as Compared to HCV-Monoinfected Patients Treated With Triple Anti-HCV Therapy.

Soria A, Limonta S, Leone S, Muscatello A, Squillace N, Bandera A, Gori A.

J Acquir Immune Defic Syndr. 2015 May 1;69(1):e37-40. doi: 10.1097/QAI.0000000000000541. No abstract available.

PMID:
25942467
49.

Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.

Bandera A, Gori A, Sabbatini F, Madeddu G, Bonora S, Libertone R, Mastroianni C, Bonfanti P, d'Arminio Monforte A, Cozzi-Lepri A; Icona Foundation Study Group.

PLoS One. 2015 May 1;10(5):e0124252. doi: 10.1371/journal.pone.0124252. eCollection 2015.

50.

First Insights into the Genome of the N-Methylhydantoin-Degrading Clostridium sp. Strain FS41 (DSM 6877).

Poehlein A, Bandera A, Horne D, Maier J, Pawlowicz D, Siebert V, Daniel R.

Genome Announc. 2015 Apr 30;3(2). pii: e00394-15. doi: 10.1128/genomeA.00394-15.

Supplemental Content

Loading ...
Support Center